Skip to main content
Clinical Trials/NCT01144715
NCT01144715
Completed
Phase 4

An Innovative Home Stroke Rehabilitation and Monitoring System

Kinetic Muscles2 sites in 1 country99 target enrollmentJune 2010
ConditionsStroke

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Stroke
Sponsor
Kinetic Muscles
Enrollment
99
Locations
2
Primary Endpoint
Action Research Arm Test (ARAT)
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this research is to evaluate a therapy delivery system for stroke patients that provide accessible, affordable stroke care. User-friendly home therapy robots and a telerehabilitation system are combined to monitor and provide therapy that is accessible for patients in rural and underserved locations. The robotic-based home therapy intervention will produce significantly greater improvement in upper extremity motor function than Usual and Customary Care enhanced with a (non-robotic) home therapy upper extremity rehabilitation program at the end of 8 weeks of home therapy.

Detailed Description

The primary purpose of this proposal is to evaluate a combined clinic/home robotic-based stroke therapy delivery and monitoring system in rural and underserved locations that provides accessible, effective and affordable care for stroke survivors with residual limb impairment. The study is a prospective, single-blind, multi-site Randomized Controlled Trial. A total of 96 patients within 6 months post-stroke will be enrolled and randomly assigned to one of two groups: robotic based home therapy or a self administered (non-robotic) home therapy program.

Registry
clinicaltrials.gov
Start Date
June 2010
End Date
September 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Kinetic Muscles
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Unilateral ischemic or hemorrhagic stroke
  • within 6 months of admission to in-patient rehabilitation
  • Persistent hemiparesis
  • Proximal Upper Extremity voluntary activity
  • Preserved cognitive function
  • Difficult access to an organized stroke rehabilitation program

Exclusion Criteria

  • Not independent before stroke
  • Hemispatial neglect
  • Significant other illnesses

Outcomes

Primary Outcomes

Action Research Arm Test (ARAT)

Time Frame: End of treatment at 8 weeks post enrolment

The amount of recovery of arm-hand function is measured with the Action Research Arm Test (ARAT). The ARAT assesses activity limitations of the upper extremity. It includes 19 items divided into four subscales: grasp, grip, pinch, and gross movement. Scores range from 0-to-57 with a higher score indicating a better outcome.

Secondary Outcomes

  • Wolf Motor Function Test(End of treatment at 8 weeks post enrolment)
  • Fugl-Meyer Upper Extremity Test(End of Treatment at 8 weeks post enrolment)
  • Stroke Impact Scale (SIS)(End of treatment at 8 weeks post enrolment)

Study Sites (2)

Loading locations...

Similar Trials